ATE440132T1 - Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger - Google Patents
Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserregerInfo
- Publication number
- ATE440132T1 ATE440132T1 AT03768918T AT03768918T ATE440132T1 AT E440132 T1 ATE440132 T1 AT E440132T1 AT 03768918 T AT03768918 T AT 03768918T AT 03768918 T AT03768918 T AT 03768918T AT E440132 T1 ATE440132 T1 AT E440132T1
- Authority
- AT
- Austria
- Prior art keywords
- bacillus subtilis
- use against
- against animal
- human diseases
- factor
- Prior art date
Links
- 244000063299 Bacillus subtilis Species 0.000 title abstract 3
- 235000014469 Bacillus subtilis Nutrition 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 241000193468 Clostridium perfringens Species 0.000 abstract 2
- 230000000845 anti-microbial effect Effects 0.000 abstract 2
- 241000589877 Campylobacter coli Species 0.000 abstract 1
- 241000589875 Campylobacter jejuni Species 0.000 abstract 1
- 241000193163 Clostridioides difficile Species 0.000 abstract 1
- 241000193998 Streptococcus pneumoniae Species 0.000 abstract 1
- 244000037640 animal pathogen Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 244000052637 human pathogen Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/306,365 US7247299B2 (en) | 2002-11-27 | 2002-11-27 | Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens |
| PCT/US2003/036094 WO2004050832A2 (en) | 2002-11-27 | 2003-11-12 | Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE440132T1 true ATE440132T1 (de) | 2009-09-15 |
Family
ID=32325671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03768918T ATE440132T1 (de) | 2002-11-27 | 2003-11-12 | Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7247299B2 (https=) |
| EP (1) | EP1576120B1 (https=) |
| JP (1) | JP4989851B2 (https=) |
| AT (1) | ATE440132T1 (https=) |
| AU (1) | AU2003291514B2 (https=) |
| CA (1) | CA2503130C (https=) |
| DE (1) | DE60328916D1 (https=) |
| ES (1) | ES2331993T3 (https=) |
| NZ (1) | NZ568391A (https=) |
| WO (1) | WO2004050832A2 (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004104175A2 (en) * | 2003-05-14 | 2004-12-02 | University Of Georgia Research Foundation, Inc. | Probiotic bacteria and methods |
| CA2566617C (en) * | 2004-05-14 | 2013-12-31 | Agtech Products, Inc. | Method and composition for reducing e.coli disease and enhancing performance using bacillus |
| RU2383622C2 (ru) * | 2005-11-04 | 2010-03-10 | Эй Эйч Си КО., ЛТД. | Антибактериальное вещество dm0507 и его применение |
| US20080057047A1 (en) * | 2005-11-29 | 2008-03-06 | Benedikt Sas | Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases |
| US7754469B2 (en) * | 2005-11-30 | 2010-07-13 | Agtech Products, Inc | Microorganisms and methods for treating poultry |
| US8021654B2 (en) | 2008-03-14 | 2011-09-20 | Danisco A/S | Methods of treating pigs with Bacillus strains |
| DK2274415T3 (da) | 2008-04-17 | 2016-04-04 | Dupont Nutrition Biosci Aps | Anvendelige bacillestammer til bekæmpelse af dyrelugt |
| US8540981B1 (en) | 2008-07-07 | 2013-09-24 | Dupont Nutrition Biosciences Aps | Bacillus strains useful against calf pathogens and scours |
| DK2754354T3 (en) | 2008-09-17 | 2016-03-21 | Bayer Cropscience Lp | A method of using a Bacillus subtilis strain to improve the animal health |
| JP5620392B2 (ja) * | 2008-11-03 | 2014-11-05 | タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ | クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物 |
| JP5578375B2 (ja) | 2010-02-10 | 2014-08-27 | 日環科学株式会社 | 好熱性微生物を用いた混合物、溶解液、及び医薬品 |
| EP2547348B1 (en) * | 2010-03-17 | 2015-05-20 | Bayer Cropscience LP | Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions |
| WO2012009712A2 (en) | 2010-07-16 | 2012-01-19 | The Board Of Trustees Of The University Of Arkansas | Methods and compositions including spore-forming bacteria for increasing the health of animals |
| US9144588B2 (en) * | 2010-09-15 | 2015-09-29 | Investigacion De Tecnologia Avanzada, S.A. De C.V. | Bacillus subtilis isolate from corn |
| US9107938B2 (en) | 2010-09-30 | 2015-08-18 | The Board Of Trustees Of The University Of Arkansas | Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads |
| US9023345B2 (en) * | 2011-03-01 | 2015-05-05 | Novus International, Inc. | Methods for improving gut health |
| CA2834382C (en) | 2011-04-29 | 2020-07-21 | Auburn University | Bacillus bacteria for use in treating and preventing infection in aquatic animals |
| US8557234B1 (en) | 2011-05-18 | 2013-10-15 | Dupont Nutrition Biosciences Aps | Methods of controlling pit foam |
| RU2014119583A (ru) | 2011-08-24 | 2015-11-20 | ДЮПОНТ НЬЮТРИШЭН БАЙОСАЙНСИЗ ЭйПиЭс | Штамм бацилл и содержащая его композиция |
| MX2014009103A (es) | 2012-01-27 | 2015-11-18 | Gfs Corp Aus Pty Ltd | Métodos para producir biosurfactantes. |
| WO2014022572A1 (en) | 2012-08-01 | 2014-02-06 | Pacific Vet Group-Usa, Inc. | Probiotic for amelioration of coccidiosis vaccine reaction |
| RU2534356C2 (ru) * | 2012-10-04 | 2014-11-27 | Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Россельхозакадемии (ГНУ ИЭВСиДВ Россельхозакадемии) | Способ контроля качества дезинфекции птицеводческих помещений |
| WO2014151837A1 (en) | 2013-03-15 | 2014-09-25 | Bayer Cropscience Lp | A bacillus subtilis strain for use in maintaining or improving the paw health of poultry |
| WO2016060934A1 (en) * | 2014-10-08 | 2016-04-21 | Novozymes A/S | Bacillus strains with fast germination and antimicrobial activity against clostridium perfringens |
| US11166989B2 (en) | 2015-01-23 | 2021-11-09 | Novozymes A/S | Bacillus strains improving health and performance of production animals |
| EP3261653B1 (en) | 2015-01-23 | 2019-10-09 | Novozymes A/S | Bacillus subtilis subspecies |
| WO2016118840A1 (en) | 2015-01-23 | 2016-07-28 | Novozymes A/S | Bacillus strains improving health and performance of production animals |
| US10201574B1 (en) | 2015-09-16 | 2019-02-12 | Church & Dwight Co., Inc. | Methods of microbial treatment of poultry |
| US11298383B2 (en) | 2016-05-20 | 2022-04-12 | Church & Dwight Co., Inc. | Lactobacillus and bacillus based direct fed microbial treatment for poultry and method of use |
| EP3464648A1 (en) | 2016-05-25 | 2019-04-10 | Church & Dwight Co., Inc. | Bacillus compositions and methods of use with ruminants |
| US11173184B2 (en) | 2016-05-31 | 2021-11-16 | Evonik Operations Gmbh | Bacillus subtilis strain with probiotic activity |
| MX2018014497A (es) | 2016-05-31 | 2019-04-15 | Evonik Degussa Gmbh | Cepa de bacillus licheniformis con actividad probiotica. |
| EP3645750A1 (en) | 2017-06-30 | 2020-05-06 | Evonik Operations GmbH | Bacillus pumilus |
| WO2019002471A1 (en) | 2017-06-30 | 2019-01-03 | Evonik Degussa Gmbh | DEBACILLUS SUBTILIS STRAIN HAVING PROBIOTIC ACTIVITY |
| US11622569B2 (en) | 2017-07-24 | 2023-04-11 | Church & Dwight Co., Inc. | Bacillus microbial terroir for pathogen control in swine |
| WO2019038153A1 (en) | 2017-08-24 | 2019-02-28 | Evonik Degussa Gmbh | DEBACILLUS SUBTILIS STRAIN HAVING PROBIOTIC ACTIVITY |
| EP3447122A1 (en) | 2017-08-24 | 2019-02-27 | Evonik Degussa GmbH | Bacillus subtilis strain with probiotic activity |
| CN108865953B (zh) * | 2018-07-25 | 2021-07-13 | 中国海洋大学 | 一株广谱抑制水产病原性弧菌的芽孢杆菌及其复合菌制剂 |
| CN113330107A (zh) | 2019-01-10 | 2021-08-31 | 赢创运营有限公司 | 发酵液及其用途 |
| JP7689077B2 (ja) | 2019-02-11 | 2025-06-05 | エボニック オペレーションズ ゲーエムベーハー | バシラエン産生細菌またはその調製物を含有する組成物 |
| CN110894132A (zh) * | 2019-12-17 | 2020-03-20 | 海天水务集团股份公司 | 一种基于fcr的污水处理方法 |
| EP4090774A1 (en) | 2020-01-14 | 2022-11-23 | Evonik Operations GmbH | Bacillus strains with the ability to degrade inorganic nitrogen compounds |
| CA3164679A1 (en) | 2020-01-17 | 2021-07-22 | Matthew Bryon BIGGS | Compositions and methods for controlling undesirable microbes and improving animal health |
| AU2021236400A1 (en) * | 2020-03-13 | 2022-09-15 | Kemin Industries, Inc. | A method for controlling clostridium infection in animals |
| EP4258875A4 (en) | 2020-12-09 | 2024-11-20 | Purina Animal Nutrition LLC | Feed compositions and methods for inhibiting focal ulcerative dermatitis |
| EP4130258A1 (en) | 2021-08-02 | 2023-02-08 | Evonik Operations GmbH | Microorganisms displaying viral decoy receptors |
| EP4166002A1 (en) | 2021-10-12 | 2023-04-19 | Evonik Operations GmbH | Microbial preparations containing specific cryoprotectants |
| EP4230722A1 (en) | 2022-02-17 | 2023-08-23 | Evonik Operations GmbH | Bacillota strains with improved outgrowth |
| EP4230721A1 (en) | 2022-02-17 | 2023-08-23 | Evonik Operations GmbH | Microorganisms with reduced competence |
| WO2023180282A1 (en) | 2022-03-24 | 2023-09-28 | Evonik Operations Gmbh | Co-precipitates of methionylmethionine with organic compounds |
| WO2023220279A1 (en) * | 2022-05-12 | 2023-11-16 | Can Technologies, Inc. | Compositions and methods for the treatment and prevention of campylobacter infection |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4545991A (en) * | 1983-06-13 | 1985-10-08 | Merck & Co., Inc. | Difficidin and derivative antibacterials |
| ES2051712T3 (es) * | 1986-06-30 | 1994-07-01 | American Cyanamid Co | Procedimiento para producir las composiciones denominadas ll-e19020 alfa y ll-e19020 beta. |
| US4968493A (en) * | 1986-06-30 | 1990-11-06 | American Cyanamid Company | Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species |
| US5352586A (en) * | 1987-05-01 | 1994-10-04 | Biogaia Ab | Method of determining the presence of an antibiotic produced by Lactobacillus reuteri |
| JPH0818996B2 (ja) * | 1987-10-31 | 1996-02-28 | カルピス食品工業株式会社 | 抗クロストリジウム生菌剤 |
| ATE130314T1 (de) * | 1990-06-22 | 1995-12-15 | Eniricerche Spa | Bazillus subtilis mutant und verfahren zur herstellung von surfactin durch verwendung dieses mutants. |
| EP0537418B1 (en) | 1991-07-01 | 1998-05-13 | Ahc Inc. | Novel bacillus bacterium and its usage |
| ZA926834B (en) * | 1991-09-09 | 1993-03-15 | American Cyanamid Co | Antibiotic LL-E19020 Gamma. |
| DK0531640T3 (da) * | 1991-09-09 | 1998-04-27 | Hoffmann La Roche | Antibiotikum LL-E19020 Gamma |
| JP2528055B2 (ja) * | 1991-10-04 | 1996-08-28 | カルピス食品工業株式会社 | 鳥類飼料添加用腸内サルモネラ属細菌減少剤及びその使用法 |
| AU1263199A (en) | 1997-12-01 | 1999-06-16 | Eisai Co. Ltd. | Novel (bacillus subtilis) with antibacterial effects |
| UA78486C2 (uk) * | 1999-12-10 | 2007-04-10 | Хемджен Корпорейшн | Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти) |
-
2002
- 2002-11-27 US US10/306,365 patent/US7247299B2/en not_active Expired - Lifetime
-
2003
- 2003-11-12 DE DE60328916T patent/DE60328916D1/de not_active Expired - Lifetime
- 2003-11-12 ES ES03768918T patent/ES2331993T3/es not_active Expired - Lifetime
- 2003-11-12 CA CA2503130A patent/CA2503130C/en not_active Expired - Lifetime
- 2003-11-12 NZ NZ568391A patent/NZ568391A/en not_active IP Right Cessation
- 2003-11-12 JP JP2004557192A patent/JP4989851B2/ja not_active Expired - Fee Related
- 2003-11-12 AU AU2003291514A patent/AU2003291514B2/en not_active Expired
- 2003-11-12 WO PCT/US2003/036094 patent/WO2004050832A2/en not_active Ceased
- 2003-11-12 AT AT03768918T patent/ATE440132T1/de not_active IP Right Cessation
- 2003-11-12 EP EP03768918A patent/EP1576120B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2331993T3 (es) | 2010-01-22 |
| AU2003291514A1 (en) | 2004-06-23 |
| JP2006514019A (ja) | 2006-04-27 |
| CA2503130A1 (en) | 2004-06-17 |
| WO2004050832A3 (en) | 2005-09-15 |
| US20040101525A1 (en) | 2004-05-27 |
| US7247299B2 (en) | 2007-07-24 |
| JP4989851B2 (ja) | 2012-08-01 |
| WO2004050832A2 (en) | 2004-06-17 |
| EP1576120A4 (en) | 2006-06-07 |
| AU2003291514B2 (en) | 2008-10-09 |
| CA2503130C (en) | 2012-03-13 |
| DE60328916D1 (de) | 2009-10-01 |
| EP1576120A2 (en) | 2005-09-21 |
| EP1576120B1 (en) | 2009-08-19 |
| NZ568391A (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60328916D1 (de) | Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger | |
| DE60129823D1 (de) | Stickstoffoxid zur behandlung therapieresistenter organismen | |
| Liu et al. | Frequency of biocide-resistant genes and susceptibility to chlorhexidine in high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MuH MRSA) | |
| Bin-Asif et al. | The genus Enterococcus and its associated virulent factors | |
| WO2009088549A3 (en) | Methods of inhibiting bacterial virulence and compounds relating thereto | |
| MX336242B (es) | Uso de los compuestos a base de lantibioticos del tipo b que tienen actividad antimicrobiana. | |
| WO2004103208A3 (en) | Manufacture and use of implantable reticulated elastomeric matrices | |
| MX2009007345A (es) | Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo. | |
| SE0402406D0 (sv) | Probiotic lactobacillus strains for improved vaginal health | |
| MY147247A (en) | Organic compounds and their uses | |
| Arciola et al. | Presence of fibrinogen-binding adhesin gene in Staphylococcus epidermidis isolates from central venous catheters-associated and orthopaedic implant-associated infections | |
| WO2009022185A3 (en) | 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use | |
| DE50306587D1 (de) | Antibakterielle amid-makrozyklen | |
| TW200738249A (en) | Harmful bacterium control agent containing bacillus thuringiensis | |
| NO20044549L (no) | Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer | |
| Taz et al. | Nasal colonization of methicillin resistant Staphylococcus aureus among healthcare providers in a tertiary care hospital, Bangladesh | |
| Sood et al. | Multidrug resistant Bacillus cereus in fresh vegetables: A serious burden to public health | |
| ATE383163T1 (de) | Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen | |
| WO2007092582A3 (en) | Neutralization of bacterial spores | |
| UA85187C2 (en) | 2-aminobenzoyl derivatives | |
| Yan et al. | Complete genome sequence of Bacillus amyloliquefaciens B15 isolated from grape skin, a strain of strong inhibitory activity against fungi | |
| Handayani et al. | Staphylococcal enterotoxin a gene–carrying Staphylococcus aureus isolated from foods and its control by crude alkaloid from papaya leaves | |
| RU2003110469A (ru) | Штамм бактерий bacillus subtilis ч-13 | |
| WO2002086154A8 (en) | Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages | |
| SI1716128T1 (sl) | Substituirane 4,5,6,7-tetrahidro-benzotiazol-2-ilaminske spojine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |